These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 2770562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

  • 4. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 5. Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes.
    Saito H, Tomioka H, Sato K, Tasaka H, Tsukamura M, Kuze F, Asano K.
    J Clin Microbiol; 1989 May; 27(5):994-7. PubMed ID: 2745706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method.
    Tomioka H, Saito H, Fujii K, Sato K, Hidaka T.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):67-70. PubMed ID: 8431020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
    Maurer FP, Pohle P, Kernbach M, Sievert D, Hillemann D, Rupp J, Hombach M, Kranzer K.
    Clin Microbiol Infect; 2019 Mar; 25(3):379.e1-379.e7. PubMed ID: 29906595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S, Hua W, Wang S, Zhang Y, Chen X, Liu H, Shao L, Chen J, Zhang W.
    BMC Microbiol; 2022 Jul 08; 22(1):175. PubMed ID: 35804298
    [Abstract] [Full Text] [Related]

  • 15. Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    Yamaba Y, Ito Y, Suzuki K, Kikuchi T, Ogawa K, Fujiuchi S, Hasegawa N, Kurashima A, Higuchi T, Uchiya KI, Watanabe A, Niimi A.
    J Infect Chemother; 2019 Dec 08; 25(12):995-1000. PubMed ID: 31239192
    [Abstract] [Full Text] [Related]

  • 16. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.
    PLoS One; 2018 Dec 08; 13(9):e0203108. PubMed ID: 30222736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.